Aslan Fred 4
4 · Artiva Biotherapeutics, Inc. · Filed Mar 7, 2025
Insider Transaction Report
Form 4
Aslan Fred
DirectorPresident and CEO
Transactions
- Award
Common Stock
2025-03-05+200,000→ 416,665 total
Footnotes (2)
- [F1]Represents restricted stock unit award granted under the Issuer's 2024 Equity Incentive Plan.
- [F2]Reflects reduction in the number of shares subject to the RSU granted on July 22, 2024 from 228,905 shares to 216,665 shares. The equity award was originally calculated based on the maximum offering size of the Company's initial public offering (IPO) and such award was subsequently adjusted following the partial exercise of the underwriters option to purchase additional shares in connection with the IPO.